5533861 (SER.L) (SER) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's DiseaseApril 8 at 4:30 PM | globenewswire.comSerina Therapeutics to Present at the Jones Healthcare and Technology Innovation ConferenceApril 7 at 6:30 AM | globenewswire.comSerina Therapeutics Reports Full Year 2024 Financial Results and Recent Business HighlightsMarch 24, 2025 | globenewswire.comSerina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 MeetingMarch 24, 2025 | globenewswire.comSerina Therapeutics Appoints Dr. Jay Venkatesan to its Board of DirectorsFebruary 12, 2025 | globenewswire.comSerina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease PatientsFebruary 3, 2025 | globenewswire.comSerina Therapeutics Announces Sale of UniverXome SubsidiaryJanuary 15, 2025 | globenewswire.comSerina Therapeutics Welcomes Karen J. Wilson to its Board of DirectorsJanuary 14, 2025 | globenewswire.comSerina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024December 16, 2024 | globenewswire.comSerina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity SummitDecember 11, 2024 | globenewswire.comSerina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease PatientsDecember 2, 2024 | globenewswire.comSerina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business HighlightsNovember 12, 2024 | globenewswire.comSerina Therapeutics Makes Grants to New Employees Under Inducement PlanNovember 11, 2024 | globenewswire.comSerina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comSerina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business HighlightsAugust 9, 2024 | globenewswire.comSerina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics SummitJuly 29, 2024 | globenewswire.comSerina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and FormulationJuly 18, 2024 | globenewswire.comSerina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business HighlightsMay 14, 2024 | globenewswire.comSerina Therapeutics Appoints Dr. Simba Gill as Executive ChairmanApril 17, 2024 | globenewswire.comSerina Therapeutics Announces Completion of Merger with AgeX TherapeuticsMarch 26, 2024 | globenewswire.com Remove Ads Get 5533861 (SER.L) News Delivered to You Automatically Sign up to receive the latest news and ratings for SER and its competitors with MarketBeat's FREE daily newsletter. Email Address SER Media Mentions By Week SER Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SER News Sentiment▼0.000.38▲Average Manufacturing News Sentiment SER News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SER Articles This Week▼20▲SER Articles Average Week Remove Ads Get 5533861 (SER.L) News Delivered to You Automatically Sign up to receive the latest news and ratings for SER and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today GSK News Today Ithaca Energy News Today HUTCHMED News Today Grainger News Today Indivior News Today Bloomsbury Publishing News Today Origin Enterprises News Today Global Ports News Today India Capital Growth News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SER) was last updated on 4/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 5533861 (SER.L) Please log in to your account or sign up in order to add this asset to your watchlist. Share 5533861 (SER.L) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SER Stock Free SER Stock Alerts